Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease: early-phase trial registry
6 of 6 indexed MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 6 currently recruiting · #2,866 of 28,707 conditions by registered trial count
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease: 6 US clinical trials tracked, 6 recruiting.
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of California, San Francisco, running 2 of these trials.
Enrollment posture brief
Registry condition masld-metabolic-dysfunction-associated-steatotic-liver-disease
OPEN 6 | RECR 100% | LATE 0 | EARLY 1 | RANK #2866 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease lists 6 open slots (100% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease is recruiting above its size-band peers.
6 of 6 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease research.
University of California, San Francisco accounts for 2 of 6 trials (33.3%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease enrolment sits around 110 participants.
Median target enrolment is 110 among the 6 trials that report a genuine target (sentinel values excluded). 3 of those (50%) plan for fewer than 100 participants.
-
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease splits between interventional and observational designs.
4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Pediatric Metabolic Dysfunction-associated Steatotic Liver Disease and Food Insecurity
University of California, San Francisco
NCT07090083
Quantitative Ultrasound to Assess Steatotic Liver Disease in Children
University of California, San Diego
NCT06706856
Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis
ContextVision AB
NCT07270601
Food Insecurity and MASLD: A Fruit and Vegetable Intervention Study
University of California, San Francisco
NCT07091539
Corazones Unidos Study
University of Arizona
NCT07298213
Effect of Ketone Esters on Liver Fat Content and Metabolic Function
Washington University School of Medicine
NCT07097506
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease page
6 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of California, San Francisco sponsors the most MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease trials on record, review their full trial history before evaluating a specific study. See University of California, San Francisco's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease condition card totals 6 registered trials; most-linked intervention Physical measurements; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.